Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)
国家功能糖组学中心 (NCFG) 的蛋白质-聚糖相互作用资源
基本信息
- 批准号:10023486
- 负责人:
- 金额:$ 121.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AnimalsAntibodiesAreaAutoimmunityBacteriaBindingBinding ProteinsBiomedical ResearchCellsCollaborationsCommunicable DiseasesCommunitiesComplex MixturesCouplingDNA LibraryDataDatabasesDevelopmentDiseaseEducational process of instructingEnsureFluorescenceFundingGenerationsGlycobiologyGlycoconjugatesGlycolipidsGlycopeptidesGlycoproteinsGlycosaminoglycansHealthHigh Pressure Liquid ChromatographyHumanHuman DevelopmentImmunologyImprove AccessIndividualJournalsLabelLaboratoriesLeadLectinLibrariesMalignant NeoplasmsManuscriptsMicroarray AnalysisMicrobeModificationMolecular ConformationMonitorMonoclonal Antibody R24National Institute of General Medical SciencesNatural ResourcesOligosaccharidesOrganismOutcomePeer ReviewPeptide LibraryPolysaccharidesPost-Translational Protein ProcessingPrintingProductionProteinsPublicationsPublishingRNA libraryRecombinantsResearchResearch PersonnelResourcesServicesShotgunsSourceSulfateSystemTechnologyTimeTissuesVirusanimal databasebiological systemscell typedensityglycosylationgut microbiomeimprovedinnovationinorganic phosphatemicrobialnew technologynoveloutreachpathogenic microbepreservationprogramssuccesstoolweb site
项目摘要
Abstract/Summary
This R24 application for an NIGMS National and Regional Resource is to enable researchers in the under-
served area of glycosciences and whose research needs glycoscience expertise, to have continued and
improved access to state-of-the-art technologies to advance biomedical research and human health involving
protein-glycan interactions and glycan recognition. Glycosylation is the most common and varied post-
translational modification (PTM) in all living things, and each cell and organism generates unique PTMs and
also glycolipids. Such resources proposed here are neither available to individual laboratories, nor are these
specific technologies available commercially. With a base of ~7,000 users (83.6% new users) and hundreds of
laboratories utilizing NCFG databases and resources, respectively, related to functional glycomics, our
resource is obviously well used and represents a unique resource democratically accessible to all biomedical
researchers. The increasing demand is evidenced by the nearly 10,000 individual, different glycan microarrays
used at the NCFG resource center in just the last 4 years. Our emphasis on protein-glycan interactions is
timely because research continues to uncover clues that these interactions are key to understanding the
expression and functions of glycans in biological systems and their recognition by antibodies, glycan-binding
proteins (GBPs) and lectins, in human and animal systems, and by microbial pathogens and gut microbiome.
Our resource makes available an incredible variety of glycan microarray technologies, glycan libraries, and
multiple databases not available elsewhere. The success of our resource has resulted in over a hundred
publications by users in the past 5 years. Because of its success and rapidly increasing number of requests,
and because we are the only resource of this kind available in the glycosciences, we propose three Specific
Aims to continue making these invaluable resources accessible. Aim 1- We will continue to generate and
improve defined glycan, glycopeptide, glycoprotein, and glycolipid microarrays, along with Luminex-based
glycan-bead technologies, all unique to the resource. Aim 2- We will make available and further improve
natural bifunctional fluorescent-tags (BFTs) originally pioneered by the NCFG, and will be utilized in glycan
microarray and bead conjugations. Such novel BFTs, pioneered by the NCFG, give us advanced capabilities
to label glycans in complex mixtures, purify them, and then quantify and quantitatively print microarrays at
varying densities. Aim 3- We will continue to use BFT technology to produce and improve natural glycan
microarrays from many sources of cells, tissues, and glycoconjugates, comprising a unique and valuable tool
for the resource center. Thus, our Protein-Glycan Interaction Resource provides unique capabilities in glycan-
binding expertise and technologies, teaching opportunities, and a wide range of services and outreach to an
emerging field rapidly becoming recognized as a key factor in health and disease.
摘要/概要
NIGMS国家和区域资源的R24申请是为了使研究人员能够在
服务于糖科学领域,其研究需要糖科学专业知识,
改善获得最新技术的机会,以促进生物医学研究和人类健康,
蛋白质-聚糖相互作用和聚糖识别。糖基化是最常见和变化的后-
翻译修饰(PTM)存在于所有生物中,每个细胞和生物体都会产生独特的翻译修饰,
还有糖脂。个别化验所并没有这些资源,
商业上可用的特定技术。拥有约7,000名用户(83.6%为新用户)和数百名
实验室利用NCFG数据库和资源,分别与功能性糖组学,我们
资源显然得到了很好的利用,是所有生物医学领域都可以民主获得的独特资源。
研究人员近10,000个不同的聚糖微阵列证明了不断增长的需求
在过去的四年里,在NCFG资源中心使用。我们对蛋白质-聚糖相互作用的强调是
及时,因为研究继续发现这些相互作用是理解这些相互作用的关键的线索。
聚糖在生物系统中的表达和功能及其被抗体识别,聚糖结合
蛋白质(GBP)和凝集素,在人类和动物系统中,以及微生物病原体和肠道微生物组。
我们的资源提供了令人难以置信的各种聚糖微阵列技术,聚糖库,
其他地方没有的多个数据库。我们的资源的成功已经导致了一百多个
用户在过去五年中的出版物。由于它的成功和请求数量的迅速增加,
因为我们是糖科学中唯一可用的这种资源,我们提出了三个具体的
目的是继续使这些宝贵的资源。目标1-我们将继续创造和
改进确定聚糖、糖肽、糖蛋白和糖脂微阵列,沿着基于Luminex的
聚糖珠技术,都是资源独有的。目标2-我们将提供并进一步改进
天然双功能荧光标记(BFT)最初由NCFG开创,并将用于聚糖
微阵列和珠缀合。这种由NCFG开创的新型BFT为我们提供了先进的功能
在复杂的混合物中标记聚糖,纯化它们,然后定量和定量打印微阵列,
不同的密度。目标3-我们将继续使用BFT技术生产和改进天然聚糖
来自许多来源的细胞、组织和糖缀合物的微阵列,包括独特的和有价值的工具
为资源中心。因此,我们的蛋白质-聚糖相互作用资源提供了独特的聚糖功能,
具有约束力的专业知识和技术,教学机会,以及广泛的服务和推广,
新兴领域迅速成为公认的健康和疾病的关键因素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD D CUMMINGS其他文献
RICHARD D CUMMINGS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD D CUMMINGS', 18)}}的其他基金
Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System
使用 Lamprey 系统开发针对人类聚糖的新型碳水化合物结合抗体
- 批准号:
10454419 - 财政年份:2021
- 资助金额:
$ 121.04万 - 项目类别:
Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System
使用 Lamprey 系统开发针对人类聚糖的新型碳水化合物结合抗体
- 批准号:
10672258 - 财政年份:2021
- 资助金额:
$ 121.04万 - 项目类别:
Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System
使用 Lamprey 系统开发针对人类聚糖的新型碳水化合物结合抗体
- 批准号:
10293635 - 财政年份:2021
- 资助金额:
$ 121.04万 - 项目类别:
Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)
国家功能糖组学中心 (NCFG) 的蛋白质-聚糖相互作用资源
- 批准号:
10205105 - 财政年份:2020
- 资助金额:
$ 121.04万 - 项目类别:
Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)
国家功能糖组学中心 (NCFG) 的蛋白质-聚糖相互作用资源
- 批准号:
10442455 - 财政年份:2020
- 资助金额:
$ 121.04万 - 项目类别:
Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)
国家功能糖组学中心 (NCFG) 的蛋白质-聚糖相互作用资源
- 批准号:
10642767 - 财政年份:2020
- 资助金额:
$ 121.04万 - 项目类别:
Integrating microbial glycan arrays with genomic sequences to study host microbe interactions
将微生物聚糖阵列与基因组序列整合以研究宿主微生物相互作用
- 批准号:
9814477 - 财政年份:2019
- 资助金额:
$ 121.04万 - 项目类别:
Integrating microbial glycan arrays with genomic sequences to study host microbe interactions
将微生物聚糖阵列与基因组序列整合以研究宿主微生物相互作用
- 批准号:
10290100 - 财政年份:2019
- 资助金额:
$ 121.04万 - 项目类别:
Integrating microbial glycan arrays with genomic sequences to study host microbe interactions
将微生物聚糖阵列与基因组序列整合以研究宿主微生物相互作用
- 批准号:
10190870 - 财政年份:2019
- 资助金额:
$ 121.04万 - 项目类别:
Forging Translational Glycobiologists: Intermeshing Glycoscience Training and Clinical Education
培养转化糖生物学家:糖科学培训与临床教育的结合
- 批准号:
10201729 - 财政年份:2018
- 资助金额:
$ 121.04万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 121.04万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 121.04万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 121.04万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 121.04万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 121.04万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 121.04万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 121.04万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 121.04万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 121.04万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 121.04万 - 项目类别: